Rhenman & Partners Asset Management’s Mersana Therapeutics MRSN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,000
| Closed | -$508K | – | 92 |
|
|
2023
Q3 | $508K | Hold |
16,000
| – | – | 0.05% | 84 |
|
|
2023
Q2 | $1.32M | Buy |
16,000
+2,000
| +14% | +$165K | 0.14% | 80 |
|
|
2023
Q1 | $1.4M | Sell |
14,000
-2,000
| -13% | -$200K | 0.15% | 82 |
|
|
2022
Q4 | $2.34M | Buy |
+16,000
| New | +$2.34M | 0.24% | 80 |
|